Ecija et al.
(tr a n s-13a ). To a mixture of 3-aminopiperidone trans-12a (300
mg, 0.87 mmol) and NaHCO3 (109 mg, 1.3 mmol) in acetone
(12 mL) was added Fmoc-OSu (438 mg, 1.3 mmol). The
resulting mixture was stirred overnight at room temperature.
Then the solvent was evaporated and the residue was dissolved
in CH2Cl2. The organic layer was washed with aqueous 0.1 N
HCl solution and water, dried, and concentrated to yield
piperidone trans-13a (312 mg, 63%) after purification by
chromatography (hexane/AcOEt, 7/3): IR (NaCl) 3415, 1747,
1725, 1618 cm-1; 1H NMR (500 MHz) δ 1.49 (s, 9 H), 2.18 (m,
1 H), 2.26 (m, 1 H), 3.40 (m, 1 H), 3.63 (m, 2 H), 3.97 and 4.57
(2 d, J ) 17.0 Hz, 1 H each), 4.03-4.15 (m, 3 H), 4.41 (t, J )
9.5 Hz, 1 H), 5.23 (d, J ) 7.5 Hz, 1 H), 7.01 (t, J ) 7.5 Hz, 1
H), 7.04 (s, 1 H), 7.09 (d, J ) 8.0 Hz, 1 H), 7.11 (d, J ) 8.0 Hz,
2 H), 7.26 (d, J ) 7.0 Hz, 2 H), 7.27 (d, J ) 8.0 Hz, 1 H), 7.33
(d, J ) 8.0 Hz, 1 H), 7.37 (d, J ) 7.5 Hz, 1 H), 7.52 (d, J ) 7.0
Hz, 1 H), 7.63 (d, J ) 7.5 Hz, 2 H), 8.15 (br s, 1 H); 13C NMR
δ 27.9, 29.7, 35.9, 46.8, 47.9, 49.5, 57.2, 66.8, 81.9, 111.5, 116.0,
118.3, 119.1, 119.6, 121.1, 121.7, 125.1, 126.5, 126.8, 127.3,
136.1, 140.9, 143.7, 143.8, 156.6, 168.1, 169.5; EIMS m/z 179
(100). Anal. Calcd for C34H35N3O5‚1/5H2O: C, 71.74; H, 6.27;
N, 7.38. Found: C, 71.44; H, 6.50; N, 7.66.
tr a n s-1-[(ter t-Bu t oxyca r b on yl)m et h yl]-4-et h yl-3-{[(9-
fluorenyl)methoxycarbonyl]amino}-piperidin-2-one (tra ns-
13b). Operating as above for the preparation of trans-13a , from
aminopiperidone trans-12b (90 mg, 0.35 mmol) and NaHCO3
(44 mg, 0.52 mmol) in acetone:H2O (5 mL, 4:1), and then Fmoc-
OSu (175 mg, 0.52 mmol), piperidone trans-13b (103 mg, 61%)
was obtained after purification by chromatography (hexane/
AcOEt, 4/1): IR (NaCl) 3316, 1727, 1654 cm-1; 1H NMR δ 0.91
(m, 3 H), 1.25 (m, 1 H), 1.46 (s, 9 H), 1.67-1.87 (m, 3 H), 2.06
(m, 1 H), 3.37 (m, 2 H), 3.98 (t, J ) 9.9 Hz, 1 H), 3.85 and 4.13
(2 d, J ) 17.1 Hz, 1 H each), 4.24 (t, J ) 7.2 Hz, 1 H), 4.38
(dd, J ) 7.5 and 2.4 Hz, 2 H), 5.24 and 5.32 (2 d, J ) 9.3 and
8.4 Hz, 1 H), 7.30 (td, J ) 7.3 and 1.0 Hz, 2 H), 7.39 (d, J )
7.2 Hz, 2 H), 7.62 (t, J ) 6.7 Hz, 2 H), 7.75 (d, J ) 7.5 Hz, 2
H); 13C NMR δ 10.5, 25.0, 26.1, 27.9, 40.1, 47.0, 47.4, 49.4,
56.4, 66.8, 81.8, 119.6, 125.0, 126.8, 127.4, 127.7, 128.2, 141.0,
143.6, 143.9, 157.0, 167.8, 169.7; EIMS m/z 256 (5), 239 (9),
200 (4), 178 (100), 152 (22), 127 (42), 98 (61), 84 (47), 57 (83);
HRMS calcd for C28H34N2O5 478.2468, found 478.2482.
for C30H27N3O5‚1/2H2O: C, 69.49; H, 5.44; N, 8.10. Found: C,
69.10; H, 5.71; N, 8.06.
tr a n s-3-{[(9-Flu or en yl)m eth oxycar bon yl]am in o}-4-eth -
yl-2-oxop ip er id in e-1-a cetic Acid (tr a n s-14b). A solution of
piperidone trans-13b (50 mg, 0.1 mmol) in TFA-CH2Cl2 (10%,
2 mL) was stirred at room temperature overnight. The solvent
was then evaporated and the resulting residue was dissolved
in CH2Cl2. The organic solution was washed with 5% NaHCO3,
acidified with 1 N HCl, and extracted with CH2Cl2. The
combined organic extracts were dried and concentrated to yield
acid trans-14b (16 mg, 36%): IR (NaCl) 3319, 1723, 1650 cm-1
;
1H NMR δ 0.94 (t, J ) 6.9 Hz, 3 H), 1.25 (m, 1 H), 1.63-1.85
(m, 3 H), 2.08 (m, 1 H), 3.36 (m, 1 H), 3.57 (m, 1 H), 3.70 and
4.37 (2 d, J ) 17.8 Hz, 1 H each), 4.05 (t, J ) 10.2 Hz, 1 H),
4.24 (t, J ) 7.0 Hz, 1 H), 4.36 (d, J ) 7.8 Hz, 2 H), 6.12 (d, J
) 9.6 Hz, 1 H), 7.29 (td, J ) 7.2 and 0.9 Hz, 2 H), 7.39 (t, J )
6.9 Hz, 1 H), 7.62 (t, J ) 6.9 Hz, 2 H), 7.75 (d, J ) 7.5 Hz, 2
H); 13C NMR δ 10.5, 25.0, 26.2, 39.8, 47.1, 48.8, 50.2, 56.4,
67.0, 119.8, 125.2, 126.9, 127.5, 141.1, 143.8, 143.9, 157.4,
171.3, 172.0; EIMS m/z 196 (17), 178 (100), 165 (56). Anal.
Calcd for C24H26N2O5‚1/5TFA: C, 65.82; H, 5.93; N, 6.29.
Found: C, 65.35; H, 6.28; N, 6.12.
t r a n s-3-{[(9-F lu or e n yl)m e t h oxyca r b on yl]a m in o}-4-
p h en yl-2-oxop ip er id in e-1-a cetic Acid (tr a n s-14c). Operat-
ing as above for the preparation of trans-14b, from piperidone
trans-13c (50 mg, 0.09 mmol) and TFA-CH2Cl2 (10%, 2 mL)
carboxylic acid trans-14c (45 mg, quantitative) was obtained:
IR (NaCl) 3323, 1722, 1643 cm-1 1H NMR δ 2.13 (m, 1 H),
;
2.24 (m, 1 H), 3.27 (m, 1 H), 3.66 (m, 1 H), 3.78 (m, 1 H), 3.92
and 4.24 (2 d, J ) 17.1 Hz, 1 H each), 4.27-4.38 (m, 2 H),
4.98 (s, 2 H), 5.69 and 5.83 (2 d, J ) 8.7 Hz, 1 H),42 7.17-7.31
(m, 12 H), 7.72 (d, J ) 7.8 Hz, 1 H); 13C NMR δ 29.7, 44.3,
47.1, 48.2, 48.3, 56.9, 66.4, 119.6, 125.0, 127.0, 127.1, 127.4,
127.6, 128.2, 128.5, 136.3, 141.7, 143.7, 156.5, 170.1; EIMS
m/z 248 (2), 196 (18), 178 (100), 165 (63), 57 (16).
tr a n s-3-Aceta m id o-1-[(ter t-bu toxyca r bon yl)m eth yl]-4-
(3-in d olyl)p ip er id in -2-on e (tr a n s-15). To a solution of ami-
nopiperidone trans-12a (200 mg, 0.58 mmol) in dry CH2Cl2 (0.4
mL), under inert atmosphere at room temperature, was added
pyridine (62 µL, 0.87 mmol) and AcCl (93 µL, 1.16 mmol). The
resulting mixture was stirred for 3 h and 0.1 N HCl was then
added. The organic layer was washed with aqueous saturated
NaHCO3 solution and brine, dried, and concentrated to yield
3-acetamidopiperidone trans-15 (190 mg, 85%): IR (KBr) 3448,
tr a n s-1-[(ter t-Bu toxycar bon yl)m eth yl]-3-{[(9-flu or en yl)-
m eth oxycar bon yl]am in o}-4-ph en ylpiper idin -2-on e (tr a n s-
13c). Operating as above for the preparation of trans-13a , from
aminopiperidone trans-12c (227 mg, 0.74 mmol) and NaHCO3
(93 mg, 1.11 mmol) in acetone:H2O (5 mL, 4:1), and then Fmoc-
OSu (374 mg, 1.11 mmol), trans-13c (157 mg, 30% from trans-
11c) was obtained after purification by chromatography
1
3289, 1741, 1640 cm-1; H NMR δ 1.49 (s, 9 H), 1.77 (s, 3 H),
2.16 (qd, J ) 11.4 and 5.6 Hz, 1 H), 2.34 (dm, J ) 10.5 Hz, 1
H), 3.37 (ddd, J ) 11.7, 5.4, and 2.7 Hz, 1 H), 3.60 (td, J )
11.5 and 3.6 Hz, 1 H), 3.66 (td, J ) 11.7 and 3.8 Hz, 1 H), 3.97
and 4.16 (2 d, J ) 17.1 Hz, 1 H each), 4.71 (dd, J ) 11.4 and
9.0 Hz, 1 H), 6.01 (d, J ) 9.3 Hz, 1 H), 7.09 (t, J ) 7.5 Hz, 1
H), 7.15 (s, 1 H), 7.18 (t, J ) 6.9 Hz, 1 H), 7.37 (d, J ) 8.1 Hz,
1 H), 7.53 (d, J ) 7.8 Hz, 1 H), 8.62 (br s, 1 H); 13C NMR δ
22.9, 28.1, 30.2, 36.0, 48.0, 49.6, 55.2, 82.1, 111.6, 116.2, 118.2,
119.2, 121.1, 121.8, 126.6, 136.2, 168.2, 169.6, 170.9; CIMS
m/z 385 (M+, 100), 386 (M+ + 1, 25), 403 (M+ + 18, 1). Anal.
Calcd for C21H27N3O4: C, 65.44; H, 7.06; N, 10.90. Found: C,
65.11; H, 7.10; N, 10.85.
(hexane/AcOEt, 4/1): IR (NaCl) 3321, 1734, 1655 cm-1 1H
;
NMR δ 1.48 (s, 9 H), 2.16 (m, 1 H), 2.27 (m, 1 H), 3.32 (m, 1
H), 3.39 (m, 1 H), 3.62 (m, 1 H), 4.06 (s, 2 H), 4.15 (d, J ) 6.9
Hz, 1 H), 4.22-4.28 (m, 3 H), 5.25 (d, J ) 6.9 Hz, 1 H), 7.22-
7.29 (m, 7 H), 7.36 (t, J ) 7.2 Hz, 2 H), 7.47 (t, J ) 7.9 Hz, 2
H), 7.72 (d, J ) 7.8 Hz, 2 H); 13C NMR δ 26.0, 29.8, 44.4, 46.9,
47.9, 49.4, 57.3, 66.8, 82.0, 119.7, 125.1, 126.8, 127.0, 127.2,
127.4, 128.5, 141.0, 141.3, 143.8, 156.2, 167.9, 169.3; EIMS
m/z 196 (6), 178 (100), 57 (33).
tr a n s-3-Aceta m id o-4-(3-in d olyl)-2-oxop ip er id in e-1-a ce-
tic Acid (tr a n s-16). A solution of acetamidopiperidone trans-
15 (429 mg, 1.11 mmol) in AcOH:iPrOH:H2O (2:1:1, 60 mL)
was stirred for 24 h at 100 °C. The solvent was then evaporated
and crude acid trans-16 (358 mg, quantitative) was obtained.
An analytical sample was purified by chromatography (CH2-
Cl2/MeOH, 94/6): IR (NaCl) 3359, 1648 cm-1; 1H NMR (MeOH)
δ 1.74 (s, 3 H), 2.23 (m, 2 H), 3.38 (m, 1 H), 3.61 (m, 3 H, 6-H),
4.12 (s, 2 H), 4.59 (d, J ) 11.4 Hz, 1 H), 6.99 (td, J ) 7.2 and
1.0 Hz, 1 H), 7.07 (td, J ) 7.5 and 1.2 Hz, 1 H), 7.11 (s, 1 H),
7.32 (d, J ) 8.1 Hz, 1 H), 7.57 (d, J ) 7.5 Hz, 1 H); 13C NMR
(MeOH) δ 22.5, 30.6, 37.1, 49.0, 49.6, 56.9, 112.3, 117.0, 119.3,
119.7, 122.2, 122.3, 128.0, 137.9, 171.5, 172.5, 173.2; CIMS
m/z 329 (M+, 2), 330 (M+ + 1, 100), 347 (M+ + 18, 1).
tr a n s-3-{[(9-F lu or en yl)m eth oxyca r bon yl]a m in o}-4-(3-
in d olyl)-2-oxop ip er id in e-1-a cetic Acid (tr a n s-14a ). A so-
lution of piperidone trans-13a (266 mg, 0.47 mmol) in PrOH:
i
H2O:AcOH (1:1:2, 15 mL) was stirred for 72 h at 100 °C. The
solvent was then evaporated and carboxylic acid trans-14a
(219 mg, 91%) was obtained. An analytical sample was purified
by chromatography (hexane): IR (KBr) 3400, 1712, 1640, 1246
1
cm-1; H NMR δ 2.13 (m, 2 H), 3.41 (m, 1 H), 3.61 (m, 2 H),
4.08-4.38 (m, 5 H), 4.42 (br t, J ) 8.1 Hz, 1 H), 5.96 (d, J )
9.3 Hz, 1 H), 7.10 (br s, 1 H), 7.17 (t, J ) 7.5 Hz, 1 H), 7.36
(m, 7 H), 7.60 (d, J ) 7.2 Hz, 2 H), 7.70 (d, J ) 7.2 Hz, 2 H),
8.25 (br s, 1 H); 13C NMR δ 29.3, 35.7, 46.8, 48.2, 49.6, 56.8,
66.8, 111.4, 115.7, 118.2, 119.0, 119.6, 120.9, 121.1, 121.6,
125.0, 126.5, 126.8, 127.3, 135.9, 136.1, 140.8, 143.5, 143.6,
156.8, 170.4, 171.1; EIMS m/z 287 (4), 178 (100). Anal. Calcd
(42) Rotamers were observed.
9552 J . Org. Chem., Vol. 68, No. 25, 2003